Congress Program

Monday, 25 June

 07:30 Registration 
 08:25
Congress Opening and 
Welcome Address
Jacob Schachter, Director, The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 08:30
Paradigm Shift in Modern Oncology
Jacob Schachter,
Director, The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 09:00
Basic Immunology
Michal Besser,
Head of Laboratory, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 09:45
Unleashing the Immune System Against Cancer
Gal Markel, Chief Scientist, Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Israel

 10:30
Coffee Break, Poster Viewing and Visit the Exhibition

 11:00
Cell α Gene Therapy
Michal Besser, Head of Laboratory, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 11:45
Two Sides of the Mirror – Autoimmunity and Cancer Immunotherapy
Paolo AsciertoIstituto Nazionale Tumori Fondazione "G. Pascale", Italy

 12:15
Bacterial Ghosts in Immunotherapy of Cancer
Werner Lubitz, CEO / CSO, BIRD-C GmbH & Co KG, Austria

 12:45
Lunch Break, Poster Viewing and Visit the Exhibition

 13:45
Cancer Immunotherapy : Blazing the Trail with Melanoma
Caroline Robert
Head, Dermatology Unit, Gustave-Roussy Institute, France

 14:15
Current Treatment of Advanced Melanoma
Ronnie Shapira-Frommer, Oncologist, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 14:45
Translational Immune Oncology
Paolo Ascierto, Istituto Nazionale Tumori Fondazione "G. Pascale", Italy

 15:15  
Coffee Break, Poster Viewing and Visit the Exhibition

 15:30
Melanoma Case Study
Asher Nethanel, Oncology Specialist, Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Israel

 16:00
Oral Presentations from Selected Abstracts

 16:45  
End of Day One


Tuesday, 26 June


08:00  Registration 
09:00
Advanced Combinations of Immunotherapy – Current Knowledge and Future Plans
Dirk Schadendorf, Professor of Dermatology, University Hospital Essen, Germany

09:45 
NSCLC Case Study and Update on Immunotherapy in Lung Cancer
Arnold Cyjon, Deputy Director of the Oncology Institute, Assaf Harofeh Medical Center, Israel

10:30
Coffee Break, Poster Viewing and Visit the Exhibition

10:45
Immunotherapy of RCC and Urothelial Cancers and Case Study
Daniel Keizman
Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Israel

11:30
Immunotherapy for Patients with High MSI Tumors
Gal Markel, Chief Scientist, Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Israel

12:00
Resistance Mechanism of Immunotherapy
Gal Markel, Chief Scientist, Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Israel

12:30
Lunch Break, Poster Viewing and Visit the Exhibition

13:30
Oral Presentations from Selected Abstracts


14:15 
Case Studies
Asher Nethanel and Guy Ben-Betzalel
 
15:15
Coffee Break, Poster Viewing and Visit the Exhibition

15:30
Case Studies
Ronnie Shapira-Frommer and Gal Markel

 16:30
Closing Remarks
Jacob Schachter, Congress Chair